Standout Papers

Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia 2009 2026 2014 2020 2.6k
  1. Chimeric Antigen Receptor–Modified T Cells for Acute Lymphoid Leukemia (2013)
    Stephan A. Grupp, Michael Kalos et al. New England Journal of Medicine
  2. CAR T cell immunotherapy for human cancer (2018)
    Carl H. June, Roddy S. O’Connor et al. Science
  3. Chimeric antigen receptor T cells persist and induce sustained remissions in relapsed refractory chronic lymphocytic leukemia (2015)
    David Porter, Wei‐Ting Hwang et al. Science Translational Medicine
  4. Chimeric Receptors Containing CD137 Signal Transduction Domains Mediate Enhanced Survival of T Cells and Increased Antileukemic Efficacy In Vivo (2009)
    Michael C. Milone, Jonathan D. Fish et al. Molecular Therapy
  5. Distinct Signaling of Coreceptors Regulates Specific Metabolism Pathways and Impacts Memory Development in CAR T Cells (2016)
    Omkar U. Kawalekar, Roddy S. O’Connor et al. Immunity
  6. Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains (2009)
    Carmine Carpenito, Michael C. Milone et al. Proceedings of the National Academy of Sciences
  7. Clinical use of lentiviral vectors (2018)
    Michael C. Milone, Una O’Doherty Leukemia
  8. Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease (2016)
    Christoph T. Ellebrecht, Vijay Bhoj et al. Science
  9. An introduction to chimeric antigen receptor (CAR) T‐cell immunotherapy for human cancer (2019)
    Weimin Kong, Erik F. Williams et al. American Journal of Hematology
  10. Rapid manufacturing of non-activated potent CAR T cells (2022)
    Saba Ghassemi, Joseph S. Durgin et al. Nature Biomedical Engineering
  11. Precision targeting of autoantigen-specific B cells in muscle-specific tyrosine kinase myasthenia gravis with chimeric autoantibody receptor T cells (2023)
    Sangwook Oh, Xuming Mao et al. Nature Biotechnology

Immediate Impact

8 by Nobel laureates 42 from Science/Nature 317 standout
Sub-graph 1 of 11

Citing Papers

Past, present, and future of CRISPR genome editing technologies
2024 Standout
Probiotic-guided CAR-T cells for solid tumor targeting
2023 StandoutScience
119 intermediate papers

Works of Michael C. Milone being referenced

High-Affinity GD2-Specific CAR T Cells Induce Fatal Encephalitis in a Preclinical Neuroblastoma Model
2017
Reengineering chimeric antigen receptor T cells for targeted therapy of autoimmune disease
2016 StandoutScience
and 17 more

Author Peers

Author Last Decade Papers Cites
Michael C. Milone 11138 5721 4395 134 15.1k
Michael Kalos 11484 5916 4825 94 15.2k
Marcela V. Maus 9657 4734 4801 199 13.3k
Simon F. Lacey 11529 4375 3810 157 14.5k
Renier J. Brentjens 14711 6602 5037 194 17.7k
Barbara Savoldo 13580 6394 4339 204 16.1k
David M. Barrett 9747 3892 3010 130 13.7k
Isabelle Rivière 8876 4211 4079 156 11.8k
Crystal L. Mackall 9385 4754 3450 146 12.4k
Steven A. Feldman 9347 4600 3059 85 11.1k
Cameron J. Turtle 8393 3732 2937 162 11.4k

All Works

Loading papers...

Rankless by CCL
2026